| 1 |
34472720 |
10.1002/cnr2.1545 |
2022 |
Genetic features of precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement. |
ID3 |
| 2 |
34617271 |
10.1111/bjh.17874 |
2022 |
Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. |
ID3 |
| 3 |
34861191 |
10.1016/j.cell.2021.11.016 |
2022 |
An NK-like CAR T cell transition in CAR T cell dysfunction. |
ID3 |
| 4 |
35205758 |
10.3390/cancers14041010 |
2022 |
Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome. |
ID3 |
| 5 |
35504924 |
10.1038/s41467-022-30053-9 |
2022 |
IRF4 drives clonal evolution and lineage choice in a zebrafish model of T-cell lymphoma. |
ID3 |
| 6 |
35681213 |
10.1186/s13058-022-01536-w |
2022 |
Multiple roles for Bcl-3 in mammary gland branching, stromal collagen invasion, involution and tumor pathology. |
ID3 |
| 7 |
35755944 |
10.1016/j.omtm.2022.05.006 |
2022 |
Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus. |
ID3 |
| 8 |
35794096 |
10.1038/s41467-022-31355-8 |
2022 |
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. |
ID3 |
| 9 |
32255708 |
10.1080/10428194.2020.1747068 |
2021 |
Burkitt lymphoma: bridging the gap between advances in molecular biology and therapy. |
ID3 |
| 10 |
32947237 |
10.1016/j.tranon.2020.100855 |
2021 |
Identification of clinical molecular targets for childhood Burkitt lymphoma. |
ID3 |
| 11 |
32981916 |
10.3960/jslrt.20021 |
2021 |
Integrative genomic analysis focused on cell cycle genes for MYC-driven aggressive mature B-cell lymphoma. |
ID3 |
| 12 |
33106431 |
10.1073/pnas.2014308117 |
2021 |
A mosaic analysis system with Cre or Tomato expression in the mouse. |
ID3 |
| 13 |
33747936 |
10.3389/fonc.2021.622648 |
2021 |
Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma. |
ID3 |
| 14 |
34500601 |
10.3390/molecules26175167 |
2021 |
The Coffee Diterpene, Kahweol, Ameliorates Pancreatic β-Cell Function in Streptozotocin (STZ)-Treated Rat INS-1 Cells through NF-kB and p-AKT/Bcl-2 Pathways. |
ID3 |
| 15 |
34627430 |
10.19746/j.cnki.issn.1009-2137.2021.05.019 |
2021 |
[Clinical Characteristics and Prognosis Affecting-Factors of the Patients with Burkitt Lymphoma]. |
ID3 |
| 16 |
34888589 |
10.21037/aol-21-18 |
2021 |
Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants. |
ID3 |
| 17 |
30008847 |
10.3892/ol.2018.8849 |
2020 |
Inhibitor of DNA binding 3 reverses cisplatin resistance in human lung adenocarcinoma cells by regulating the PI3K/Akt pathway. |
ID3 |
| 18 |
30733272 |
10.3324/haematol.2018.207928 |
2020 |
Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma. |
ID3 |
| 19 |
30779244 |
10.1002/gcc.22743 |
2020 |
A recurrent clonally distinct Burkitt lymphoma case highlights genetic key events contributing to oncogenesis. |
ID3 |
| 20 |
31000522 |
10.1158/0008-5472.CAN-18-3438 |
2020 |
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma. |
ID3 |
| 21 |
31300419 |
10.1182/bloodadvances.2018029546 |
2020 |
Sporadic and endemic Burkitt lymphoma have frequent <i>FOXO1</i> mutations but distinct hotspots in the AKT recognition motif. |
ID3 |
| 22 |
31368914 |
10.1097/PAS.0000000000001338 |
2020 |
Indolent In Situ B-Cell Neoplasms With MYC Rearrangements Show Somatic Mutations in MYC and TNFRSF14 by Next-generation Sequencing. |
ID3 |
| 23 |
31558468 |
10.1182/blood.2019001880 |
2020 |
The whole-genome landscape of Burkitt lymphoma subtypes. |
ID3 |
| 24 |
31738823 |
10.1182/blood.2019002699 |
2020 |
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. |
ID3 |
| 25 |
31980558 |
10.1136/jclinpath-2019-206282 |
2020 |
Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia and description of its mutational profiles by targeted NGS. |
ID3 |
| 26 |
32059783 |
10.1016/j.cell.2020.01.029 |
2020 |
Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody. |
ID3 |
| 27 |
28724958 |
10.1038/s41598-017-05713-2 |
2019 |
Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell lines. |
ID3 |
| 28 |
29534361 |
10.3760/cma.j.issn.0529-5807.2018.03.011 |
2019 |
[Expression and prognostic significance of ID3 and TCF3 protein in invasive B cell lymphoma]. |
ID3 |
| 29 |
30567752 |
10.1182/blood-2018-07-864025 |
2019 |
The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma. |
ID3 |
| 30 |
30623224 |
10.1007/s00347-018-0840-8 |
2019 |
[New molecular pathological strategies for malignant iris tumors]. |
ID3 |
| 31 |
26992947 |
10.3324/haematol.2015.138701 |
2018 |
Immunohistochemical detection of inhibitor of DNA binding 3 mutational variants in mature aggressive B-cell lymphoma. |
ID3 |
| 32 |
28209658 |
10.3324/haematol.2016.156885 |
2018 |
Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols. |
ID3 |
| 33 |
28245840 |
10.1186/s13046-017-0506-4 |
2018 |
Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL. |
ID3 |
| 34 |
28664939 |
10.1038/modpathol.2017.58 |
2018 |
Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms. |
ID3 |
| 35 |
27810071 |
10.1016/j.cancergen.2016.08.007 |
2017 |
MYC rearranged B-cell neoplasms: Impact of genetics on classification. |
ID3 |
| 36 |
27888884 |
10.1016/j.hoc.2016.07.009 |
2017 |
Update on Burkitt Lymphoma. |
ID3 |
| 37 |
28258199 |
10.4049/jimmunol.1601935 |
2017 |
Id2 Collaborates with Id3 To Suppress Invariant NKT and Innate-like Tumors. |
ID3 |
| 38 |
28801451 |
10.1182/blood-2017-02-767335 |
2017 |
Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets. |
ID3 |
| 39 |
26173642 |
10.1002/gcc.22268 |
2016 |
The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma. |
ID3 |
| 40 |
26437030 |
10.1038/ng.3413 |
2016 |
DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control. |
ID3 |
| 41 |
26468873 |
10.1371/journal.ppat.1005158 |
2016 |
Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma. |
ID3 |
| 42 |
26567765 |
10.1111/bjh.13849 |
2016 |
The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab. |
ID3 |
| 43 |
26712879 |
10.1093/ajcp/aqv011 |
2016 |
Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma. |
ID3 |
| 44 |
26887776 |
10.1111/bjh.13925 |
2016 |
Genetic differences between paediatric and adult Burkitt lymphomas. |
ID3 |
| 45 |
27044543 |
10.1186/s13046-016-0333-z |
2016 |
High expression of ID family and IGJ genes signature as predictor of low induction treatment response and worst survival in adult Hispanic patients with B-acute lymphoblastic leukemia. |
ID3 |
| 46 |
24867287 |
10.1097/MOH.0000000000000059 |
2015 |
New clues to the molecular pathogenesis of Burkitt lymphoma revealed through next-generation sequencing. |
ID3 |
| 47 |
25248476 |
10.1016/B978-0-12-405943-6.00004-X |
2015 |
E proteins in lymphocyte development and lymphoid diseases. |
ID3 |
| 48 |
25691468 |
10.1101/gad.255331.114 |
2015 |
The E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to suppress innate variant TFH cell development, thymocyte expansion, and lymphomagenesis. |
ID3 |
| 49 |
24222112 |
|
2014 |
ID3 mutations are recurrent events in double-hit B-cell lymphomas. |
ID3 |
| 50 |
24426788 |
10.2147/CMAR.S37745 |
2014 |
Developments in Burkitt's lymphoma: novel cooperations in oncogenic MYC signaling. |
ID3 |
| 51 |
24463518 |
10.1038/nature12910 |
2014 |
Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development. |
ID3 |
| 52 |
24492847 |
10.1101/cshperspect.a014282 |
2014 |
Oncogenic mechanisms in Burkitt lymphoma. |
ID3 |
| 53 |
24493312 |
10.1002/hon.2094 |
2014 |
The combined expression of VPREB3 and ID3 represents a new helpful tool for the routine diagnosis of mature aggressive B-cell lymphomas. |
ID3 |
| 54 |
24689848 |
10.1111/cas.12408 |
2014 |
Disease-specific mutations in mature lymphoid neoplasms: recent advances. |
ID3 |
| 55 |
22967991 |
10.1093/annonc/mds209 |
2013 |
A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome. |
ID3 |
| 56 |
23143595 |
10.1038/ng.2469 |
2013 |
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. |
ID3 |
| 57 |
23143597 |
10.1038/ng.2468 |
2013 |
The genetic landscape of mutations in Burkitt lymphoma. |
ID3 |
| 58 |
23192177 |
10.1038/ng.2476 |
2013 |
New pathogenic mechanisms in Burkitt lymphoma. |
ID3 |
| 59 |
23782073 |
10.1586/ehm.13.27 |
2013 |
Genetic sequencing studies in Burkitt's lymphoma: what can we learn about tumorigenesis? |
ID3 |
| 60 |
23980171 |
10.1073/pnas.1309378110 |
2013 |
The transcription factor Interferon Regulatory Factor 4 is required for the generation of protective effector CD8+ T cells. |
ID3 |
| 61 |
21948191 |
10.1093/intimm/dxr078 |
2012 |
Transcriptional control of T-cell development. |
ID3 |
| 62 |
22885699 |
10.1038/nature11378 |
2012 |
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. |
ID3 |
| 63 |
20852128 |
10.1182/blood-2010-03-274506 |
2011 |
Mutation of inhibitory helix-loop-helix protein Id3 causes γδ T-cell lymphoma in mice. |
ID3 |
| 64 |
21921784 |
10.1097/PAS.0b013e318224d2cd |
2011 |
Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins. |
ID3 |
| 65 |
19608273 |
10.1016/j.leukres.2009.06.020 |
2010 |
Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines. |
ID3 |
| 66 |
19022773 |
10.1074/jbc.M808080200 |
2009 |
TGF-beta induces growth arrest in Burkitt lymphoma cells via transcriptional repression of E2F-1. |
ID3 |
| 67 |
18069898 |
10.1371/journal.pgen.0030219 |
2008 |
A mechanism misregulating p27 in tumors discovered in a functional genomic screen. |
ID3 |
| 68 |
17899540 |
10.1002/eji.200636759 |
2007 |
Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells. |
ID3 |
| 69 |
17922653 |
10.1134/s0006297907090052 |
2007 |
Transcription factors NFAT2 and Egr1 cooperatively regulate the maturation of T-lymphoma in vitro. |
ID3 |
| 70 |
15877825 |
10.1186/1471-2172-6-9 |
2006 |
BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1. |
ID3 |
| 71 |
15780199 |
10.1111/j.1745-7254.2005.00067.x |
2005 |
Engagement of membrane immunoglobulin enhances Id3 promoter activity in WEHI-231 B lymphoma cells. |
ID3 |
| 72 |
14633393 |
10.1089/106652703322539033 |
2004 |
The application of rule-based methods to class prediction problems in genomics. |
ID3 |
| 73 |
15196311 |
10.1186/1471-2172-5-11 |
2004 |
Cloning and functional characterisation of avian transcription factor E2A. |
ID3 |
| 74 |
15294959 |
10.4049/jimmunol.173.4.2453 |
2004 |
CD40 ligand rescues inhibitor of differentiation 3-mediated G1 arrest induced by anti-IgM in WEHI-231 B lymphoma cells. |
ID3 |
| 75 |
11840323 |
10.1038/sj.onc.1205091 |
2002 |
The regulation and function of the Id proteins in lymphocyte development. |
ID3 |
| 76 |
11248796 |
10.1038/77881 |
2001 |
Intertwining proteins in thymocyte development and cancer. |
ID3 |
| 77 |
10587351 |
10.1084/jem.190.11.1605 |
2000 |
Thymocyte maturation is regulated by the activity of the helix-loop-helix protein, E47. |
ID3 |
| 78 |
8632670 |
10.1016/0145-2126(95)00084-4 |
1996 |
Expression of Id2 and Id3 mRNA in human lymphocytes. |
ID3 |
| 79 |
8652837 |
|
1996 |
Id2 expression increases with differentiation of human myeloid cells. |
ID3 |
| 80 |
8674709 |
10.1042/bst024004s |
1996 |
Early response gene expression in Ras oncoprotein signalling. |
ID3 |
Datasets
Models
